Moneycontrol PRO
you are here: HomeNewsIndia

DGCA extends ban on international passenger flights until September 30

The restriction doesn't apply to international all-cargo operations and flights specifically approved by DGCA.

August 29, 2021 / 12:14 PM IST

The Directorate General of Civil Aviation (DGCA) has extended the ban on international scheduled commercial passenger flights to and from India, which was scheduled to end on August 31. The ban is now extended till September 30.

"In partial modification of circular dated 26-06-2020, the competent authority has further extended the validity of circular issued on the subject cited above regarding Scheduled International commercial passenger services to/from India till 2359 hrs IST of September 30, 2021," the DGCA circular said.

International scheduled flights may be allowed on selected routes by the competent authority on case to case basis, DGCA said in a circular.

The restriction doesn't apply to international all-cargo operations and flights specifically approved by DGCA.

Scheduled international passenger flights were suspended in India on March 23 due to the coronavirus pandemic. The aviation authority has extended the ban several times since then.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
While domestic flights resumed in May, international travel remained suspended as COVID-19 cases remained at high levels.
Moneycontrol News
first published: Aug 29, 2021 12:06 pm
ISO 27001 - BSI Assurance Mark